Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences (Financial Times)
·
0 reactions
·
0 comments
·
6 views
Financial Times : Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences — Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences
Original article
Techmeme
Anonymous · no account needed